BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 1525339)

  • 1. Fungal infections in cancer patients: an escalating problem.
    Samonis G; Bafaloukos D
    In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prophylaxis against mycoses in neutropenic patients].
    Arning M; Aul C
    Mycoses; 1994; 37 Suppl 2():70-6. PubMed ID: 7541892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D; Nemet D
    Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mycoses and their treatment in malignant hemopathies].
    Martino P; Girmenia C
    Recenti Prog Med; 1999 Mar; 90(3):160-8. PubMed ID: 10228357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of invasive mycoses in North America.
    Pfaller MA; Diekema DJ
    Crit Rev Microbiol; 2010; 36(1):1-53. PubMed ID: 20088682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New aspects in treatment of systemic mycoses].
    Presterl E; Graninger W
    Wien Klin Wochenschr; 1998 Nov; 110(21):740-50. PubMed ID: 9871965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspergillus to Zygomycetes: causes, risk factors, prevention, and treatment of invasive fungal infections.
    Cornely OA
    Infection; 2008 Aug; 36(4):296-313. PubMed ID: 18642109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liposomal amphotericin B: what is its role in 2008?
    Lanternier F; Lortholary O
    Clin Microbiol Infect; 2008 May; 14 Suppl 4():71-83. PubMed ID: 18430132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trends in the epidemiology of opportunistic fungal infections: predisposing factors and the impact of antimicrobial use practices.
    Singh N
    Clin Infect Dis; 2001 Nov; 33(10):1692-6. PubMed ID: 11641825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal infections associated with malignancies, treatments, and AIDS.
    Benedict S; Colagreco J
    Cancer Nurs; 1994 Oct; 17(5):411-7. PubMed ID: 7954389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic fungal infections: major problems in cancer patients.
    Powles RL; Mehta J
    Indian J Cancer; 1994 Sep; 31(3):180-4. PubMed ID: 8557296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fungal infections: a growing threat.
    Dixon DM; McNeil MM; Cohen ML; Gellin BG; La Montagne JR
    Public Health Rep; 1996; 111(3):226-35. PubMed ID: 8643813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fungal infections in solid organ transplant recipients.
    Hadley S; Karchmer AW
    Infect Dis Clin North Am; 1995 Dec; 9(4):1045-74. PubMed ID: 8747778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fungal infections in leukemic patients: our experience during 5 years].
    Torre MA; Escalante R; López Martín JC; de la Maya MD; Martínez Estéfano E; López Lacomba D; González Aza C
    Sangre (Barc); 1996 Oct; 41(5):395-7. PubMed ID: 9026926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic action of oral fluconazole against fungal infection in neutropenic patients. A meta-analysis of 16 randomized, controlled trials.
    Kanda Y; Yamamoto R; Chizuka A; Hamaki T; Suguro M; Arai C; Matsuyama T; Takezako N; Miwa A; Kern W; Kami M; Akiyama H; Hirai H; Togawa A
    Cancer; 2000 Oct; 89(7):1611-25. PubMed ID: 11013378
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.